Founded in 1978, it is a well-known trademark in Shanxi Province, focusing on Chinese and Western medicine preparations/APIs and pharmaceutical packaging materials, committed to the use of drugs for chronic diseases of the elderly and women and children, and is an enterprise integrating R&D, production, sales and planting of Chinese herbal medicines
Yabao Pharmaceutical Group Co., Ltd. is the first listed company and the first batch of high-tech enterprises in the pharmaceutical industry in Shanxi Province. It integrates R&D, production, sales and planting of Chinese herbal medicines, with 21 subsidiaries, total assets of 4.25 billion yuan, annual sales revenue of more than 2 billion yuan, and more than 5,600 employees.The trademark "Yabao" is a well-known trademark in China.
The company has 9 production bases, 3 research bases and 2 Chinese herbal medicine planting bases in Beijing, Shanghai, Taiyuan, Chengdu, Guiyang, Yuncheng and other places. All 9 production bases have passed the new national GMP certification, among them, Beijing Biopharmaceutical has passed the US FDA cGMP certification, and the three branches have passed the EU GMP certification.
The main products include more than 300 varieties of Chinese and Western medicine preparations, raw materials and pharmaceutical packaging materials, mainly for the elderly and chronic diseases and women and children. In 2014, it won the first prize of science and technology of the China Association of Traditional Chinese Medicine, and in 2015, it won the first place in the comprehensive statistical ranking of China's non-prescription drug products (Chinese patent medicine, pediatrics).
The company has an international professional R&D team, with a total of 410 R&D personnel, including 22 doctors and 150 masters. In the declaration, production and sales of new drugs, it is in line with international standards, and has taken the step of "one place for research and development, three places for declaration; One place of production, three places of sales".
At present, there are more than 3,000 marketing personnel of various types, and a professional marketing team has been established in business channels, OTC retail, grassroots terminals, hospital investment, OTC investment, APIs, sales expansion, Beijing biology, consumer health care and other professional marketing teams. The company has a complete sales network, with sales outlets covering the first, second, third and terminal markets in 32 provinces and cities across the country, covering 661 cities and counties.
During the "13th Five-Year Plan" period, Yabao Pharmaceutical should "take medicine as the main body, health products and medical services as the two wings", on the one hand, deeply cultivate the industry, and on the other hand, leverage capital. Through the endogenous "asset management" and the extension of the "capital operation" two-wheel drive, to promote the rapid development of enterprises. Through the creation of 5 centers, the establishment of 10 systems, the creation of 6 capabilities, and the realization of 6 transformations. Eventually, it will become a leader in the children's health industry; To become the most innovative pharmaceutical company in China; It has become a model for the internationalization of China's pharmaceutical industry.
